Keros Therapeutics Inc
KROS14.620USD
+0.300+2.09%
終値 08/04, 16:00（ET）15分遅れの株価
14.620USD+14.620時間外取引 (ET)
593.02M時価総額
140.79直近12ヶ月PER
四半期
四半期+年間
四半期
年間
YOY
空白行を非表示にする
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
総売上高
254413.25%211.25M
2027.27%3.04M
4750.00%388.00K
--37.00K
--83.00K
--143.00K
--8.00K
----
----
-100.00%0.00
--0.00
-100.00%0.00
----
--20.00M
--0.00
--100.00K
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--2.50M
--2.50M
--2.50M
--2.50M
収益
254413.25%211.25M
2027.27%3.04M
4750.00%388.00K
--37.00K
--83.00K
--143.00K
--8.00K
----
----
-100.00%0.00
--0.00
-100.00%0.00
----
--20.00M
--0.00
--100.00K
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--2.50M
--2.50M
--2.50M
--2.50M
営業費用
21.91%59.21M
20.81%56.30M
36.40%59.05M
22.11%50.48M
24.95%48.57M
45.80%46.60M
54.73%43.29M
34.53%41.34M
61.11%38.87M
28.53%31.96M
38.52%27.98M
96.46%30.73M
53.00%24.13M
87.09%24.87M
69.04%20.20M
43.31%15.64M
50.12%15.77M
154.23%13.29M
147.58%11.95M
111.88%10.91M
96.04%10.50M
--5.23M
--4.83M
--5.15M
--5.36M
研究 & 開発費
27.32%48.71M
21.71%45.63M
44.19%49.23M
24.53%40.52M
23.05%38.26M
50.77%37.49M
62.27%34.14M
39.74%32.53M
71.98%31.09M
32.04%24.87M
41.85%21.04M
133.21%23.28M
57.27%18.08M
94.68%18.83M
76.68%14.83M
37.43%9.98M
34.81%11.49M
132.49%9.67M
117.83%8.39M
61.53%7.26M
75.20%8.53M
--4.16M
--3.85M
--4.50M
--4.87M
減価償却費、減耗費および償却費
24.19%344.00K
34.41%332.00K
49.52%314.00K
60.21%306.00K
65.87%277.00K
94.49%247.00K
66.67%210.00K
-37.99%191.00K
47.79%167.00K
22.12%127.00K
22.33%126.00K
238.46%308.00K
41.25%113.00K
38.67%104.00K
43.06%103.00K
33.82%91.00K
26.98%80.00K
27.12%75.00K
30.91%72.00K
38.78%68.00K
40.00%63.00K
--59.00K
--55.00K
--49.00K
--45.00K
営業利益
413.59%152.04M
-14.64%-53.25M
-35.53%-58.66M
-22.02%-50.44M
-24.73%-48.48M
-45.35%-46.45M
-54.70%-43.28M
-34.53%-41.34M
-61.11%-38.87M
-556.80%-31.96M
-38.52%-27.98M
-97.72%-30.73M
-53.00%-24.13M
63.39%-4.87M
-69.04%-20.20M
-42.40%-15.54M
-50.12%-15.77M
-387.21%-13.29M
-413.67%-11.95M
-311.69%-10.91M
-267.53%-10.50M
---2.73M
---2.33M
---2.65M
---2.86M
営業外受取（支払）利息純額
有価証券売却益
16.98%6.79M
-55.82%6.52M
--5.79M
--5.38M
--5.81M
--14.76M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
特別利益（損失）
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
-146.69%-1.49M
---78.00K
---1.23M
---647.00K
---604.00K
その他営業外収益（費用）
22.65%-338.00K
111.81%1.01M
-102.40%-92.00K
-105.11%-196.00K
-114.26%-437.00K
-481.04%-8.54M
-14.04%3.84M
10.69%3.83M
5294.92%3.06M
3129.73%2.24M
3360.58%4.47M
4427.50%3.46M
9.23%-59.00K
-102.83%-74.00K
-59.30%-137.00K
-150.63%-80.00K
4.41%-65.00K
4571.43%2.62M
-673.33%-86.00K
-64.65%158.00K
-124.20%-68.00K
--56.00K
--15.00K
--447.00K
--281.00K
税引前利益
467.62%158.49M
-13.62%-45.73M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.80M
-501.46%-29.72M
-15.61%-23.51M
-74.54%-27.27M
-52.74%-24.19M
53.72%-4.94M
-68.95%-20.34M
-45.23%-15.62M
-31.26%-15.84M
-288.08%-10.68M
-239.14%-12.04M
-277.04%-10.76M
-279.01%-12.06M
---2.75M
---3.55M
---2.85M
---3.18M
法人税等
--10.04M
--300.00K
----
----
----
--0.00
----
----
----
-100.00%0.00
100.00%0.00
--0.00
-100.00%0.00
--2.00M
---38.00K
--0.00
--50.00K
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
税引後利益
444.32%148.45M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.80M
-328.21%-29.72M
-15.82%-23.51M
-74.54%-27.27M
-52.26%-24.19M
34.99%-6.94M
-68.64%-20.30M
-45.23%-15.62M
-31.67%-15.88M
-288.08%-10.68M
-239.14%-12.04M
-277.04%-10.76M
-279.01%-12.06M
---2.75M
---3.55M
---2.85M
---3.18M
継続事業による純利益
444.32%148.45M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.80M
-328.21%-29.72M
-15.82%-23.51M
-74.54%-27.27M
-52.26%-24.19M
34.99%-6.94M
-68.64%-20.30M
-45.23%-15.62M
-31.67%-15.88M
-288.08%-10.68M
-239.14%-12.04M
-277.04%-10.76M
-279.01%-12.06M
---2.75M
---3.55M
---2.85M
---3.18M
非経常純利益
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--172.00K
----
----
----
----
親会社株主に帰属する当期純利益
444.32%148.45M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.80M
-328.21%-29.72M
-15.82%-23.51M
-74.54%-27.27M
-52.26%-24.19M
28.19%-6.94M
-68.64%-20.30M
-42.50%-15.62M
-25.10%-15.88M
-589.79%-9.66M
-200.98%-12.04M
-231.91%-10.96M
-249.52%-12.70M
---1.40M
---4.00M
---3.30M
---3.63M
優先株配当金
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
----
-100.00%0.00
-54.22%206.00K
79.11%806.00K
----
--450.00K
--450.00K
--450.00K
普通株主に帰属する純利益
444.32%148.45M
-14.37%-46.03M
-34.27%-52.96M
-20.67%-45.26M
-20.42%-43.11M
-35.42%-40.24M
-67.77%-39.44M
-37.55%-37.51M
-48.04%-35.80M
-328.21%-29.72M
-15.82%-23.51M
-74.54%-27.27M
-52.26%-24.19M
28.19%-6.94M
-68.64%-20.30M
-42.50%-15.62M
-25.10%-15.88M
-589.79%-9.66M
-200.98%-12.04M
-231.91%-10.96M
-249.52%-12.70M
---1.40M
---4.00M
---3.30M
---3.63M
基本的1株当たり利益
402.94%3.66
14.61%-1.14
-5.97%-1.41
1.06%-1.25
4.27%-1.21
-22.90%-1.34
-44.48%-1.33
-11.77%-1.27
-25.20%-1.26
-266.95%-1.09
-5.91%-0.92
-69.11%-1.13
-47.41%-1.01
33.61%-0.30
-45.64%-0.87
-23.25%-0.67
-3.34%-0.68
-2124.49%-0.45
65.05%-0.60
-215.95%-0.54
-249.52%-0.66
---0.02
---1.71
---0.17
---0.19
希薄化後1株当たり利益
399.53%3.62
14.61%-1.14
-5.97%-1.41
1.06%-1.25
4.27%-1.21
-22.90%-1.34
-44.48%-1.33
-11.77%-1.27
-25.20%-1.26
-266.95%-1.09
-5.91%-0.92
-69.11%-1.13
-47.41%-1.01
33.61%-0.30
-45.64%-0.87
-23.25%-0.67
-3.34%-0.68
-2124.49%-0.45
65.05%-0.60
-215.95%-0.54
-249.52%-0.66
---0.02
---1.71
---0.17
---0.19
1株当たり配当金
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
通貨単位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
監査意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
